Eikon Therapeutics reports Q2 2026 results and clinical updates
Eikon Therapeutics (EIKN) reports second quarter 2026 financial results and provides clinical updates, according to a TradeXchange Newsdesk release.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.